Surfactant status in preterm neonates recovering from respiratory distress syndrome. 2008

Giovanna Verlato, and Paola Elisa Cogo, and Marco Balzani, and Antonina Gucciardi, and Ilaria Burattini, and Fernando De Benedictis, and Giovanna Martiri, and Virgilio Paolo Carnielli
Department of Pediatrics, University of Padova, Padova, Italy.

OBJECTIVE The goal was to establish whether reduced amounts of pulmonary surfactant contribute to postextubation respiratory failure in preterm infants recovering from respiratory distress syndrome. METHODS We prospectively recruited preterm infants who needed mechanical ventilation and exogenous surfactant for treatment of moderate/severe respiratory distress syndrome and could not be extubated before day 3 of life. (13)C-labeled dipalmitoyl-phosphatidylcholine was administered endotracheally as tracer before extubation, for estimation of surfactant disaturated phosphatidylcholine pool size and half-life. Patients were retrospectively divided into 3 groups, that is, extubation failure if, after extubation, they needed reintubation or continuous positive airway pressure treatment of >or=6 cmH(2)O and fraction of inspired oxygen of >0.4, extubation success if they did not meet the failure criteria, and not extubated if they needed ongoing ventilation. Clinical and respiratory parameters were recorded hourly. RESULTS Reliable kinetic data could be obtained for 63 of the 88 enrolled neonates. Sixteen, 23, and 24 neonates were categorized in the extubation failure, extubation success, and not extubated groups, respectively. Clinical and demographic characteristics did not differ between the extubation failure and extubation success groups. Disaturated phosphatidylcholine pool size was smaller in the extubation failure group than in the extubation success group (25 +/- 12 vs 43 +/- 24 mg/kg) and was 37 +/- 32 mg/kg in the not extubated group. Disaturated phosphatidylcholine half-life was 19 +/- 7, 24 +/- 12, and 28 +/- 18 hours in the extubation failure, extubation success, and not extubated groups, respectively. CONCLUSIONS In a selected population of preterm infants with moderate/severe respiratory distress syndrome who could not be extubated in the first 3 days of life, infants who were reintubated or needed high continuous positive airway pressure settings after extubation had a smaller disaturated phosphatidylcholine pool size than did those who were successfully extubated or needed low continuous positive airway pressure settings.

UI MeSH Term Description Entries
D007230 Infant, Low Birth Weight An infant having a birth weight of 2500 gm. (5.5 lb.) or less but INFANT, VERY LOW BIRTH WEIGHT is available for infants having a birth weight of 1500 grams (3.3 lb.) or less. Low Birth Weight,Low-Birth-Weight Infant,Birth Weight, Low,Birth Weights, Low,Infant, Low-Birth-Weight,Infants, Low-Birth-Weight,Low Birth Weight Infant,Low Birth Weights,Low-Birth-Weight Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007234 Infant, Premature A human infant born before 37 weeks of GESTATION. Neonatal Prematurity,Premature Infants,Preterm Infants,Infant, Preterm,Infants, Premature,Infants, Preterm,Premature Infant,Prematurity, Neonatal,Preterm Infant
D008297 Male Males
D010713 Phosphatidylcholines Derivatives of PHOSPHATIDIC ACIDS in which the phosphoric acid is bound in ester linkage to a CHOLINE moiety. Choline Phosphoglycerides,Choline Glycerophospholipids,Phosphatidyl Choline,Phosphatidyl Cholines,Phosphatidylcholine,Choline, Phosphatidyl,Cholines, Phosphatidyl,Glycerophospholipids, Choline,Phosphoglycerides, Choline
D011663 Pulmonary Surfactants Substances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI. Surfactants, Pulmonary,Pulmonary Surfactant,Surfactant, Pulmonary
D012121 Respiration, Artificial Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2). Ventilation, Mechanical,Mechanical Ventilation,Artificial Respiration,Artificial Respirations,Mechanical Ventilations,Respirations, Artificial,Ventilations, Mechanical
D012127 Respiratory Distress Syndrome, Newborn A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause. Infantile Respiratory Distress Syndrome,Neonatal Respiratory Distress Syndrome,Respiratory Distress Syndrome, Infant
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes

Related Publications

Giovanna Verlato, and Paola Elisa Cogo, and Marco Balzani, and Antonina Gucciardi, and Ilaria Burattini, and Fernando De Benedictis, and Giovanna Martiri, and Virgilio Paolo Carnielli
January 1994, Jornal de pediatria,
Giovanna Verlato, and Paola Elisa Cogo, and Marco Balzani, and Antonina Gucciardi, and Ilaria Burattini, and Fernando De Benedictis, and Giovanna Martiri, and Virgilio Paolo Carnielli
June 1985, Archives of disease in childhood,
Giovanna Verlato, and Paola Elisa Cogo, and Marco Balzani, and Antonina Gucciardi, and Ilaria Burattini, and Fernando De Benedictis, and Giovanna Martiri, and Virgilio Paolo Carnielli
January 1998, Respiration; international review of thoracic diseases,
Giovanna Verlato, and Paola Elisa Cogo, and Marco Balzani, and Antonina Gucciardi, and Ilaria Burattini, and Fernando De Benedictis, and Giovanna Martiri, and Virgilio Paolo Carnielli
August 1977, The Journal of pediatrics,
Giovanna Verlato, and Paola Elisa Cogo, and Marco Balzani, and Antonina Gucciardi, and Ilaria Burattini, and Fernando De Benedictis, and Giovanna Martiri, and Virgilio Paolo Carnielli
March 2016, Indian pediatrics,
Giovanna Verlato, and Paola Elisa Cogo, and Marco Balzani, and Antonina Gucciardi, and Ilaria Burattini, and Fernando De Benedictis, and Giovanna Martiri, and Virgilio Paolo Carnielli
January 2014, Pediatrics,
Giovanna Verlato, and Paola Elisa Cogo, and Marco Balzani, and Antonina Gucciardi, and Ilaria Burattini, and Fernando De Benedictis, and Giovanna Martiri, and Virgilio Paolo Carnielli
January 2012, Acta bio-medica : Atenei Parmensis,
Giovanna Verlato, and Paola Elisa Cogo, and Marco Balzani, and Antonina Gucciardi, and Ilaria Burattini, and Fernando De Benedictis, and Giovanna Martiri, and Virgilio Paolo Carnielli
January 2000, The Cochrane database of systematic reviews,
Giovanna Verlato, and Paola Elisa Cogo, and Marco Balzani, and Antonina Gucciardi, and Ilaria Burattini, and Fernando De Benedictis, and Giovanna Martiri, and Virgilio Paolo Carnielli
January 2006, Biology of the neonate,
Giovanna Verlato, and Paola Elisa Cogo, and Marco Balzani, and Antonina Gucciardi, and Ilaria Burattini, and Fernando De Benedictis, and Giovanna Martiri, and Virgilio Paolo Carnielli
June 2021, Children (Basel, Switzerland),
Copied contents to your clipboard!